CY1118806T1 - Υποκατεστημενα χρωμαν-6-υλοξυ-κυκλοαλκανια και η χρηση τους ως φαρμακευτικες ουσιες - Google Patents
Υποκατεστημενα χρωμαν-6-υλοξυ-κυκλοαλκανια και η χρηση τους ως φαρμακευτικες ουσιεςInfo
- Publication number
- CY1118806T1 CY1118806T1 CY20171100146T CY171100146T CY1118806T1 CY 1118806 T1 CY1118806 T1 CY 1118806T1 CY 20171100146 T CY20171100146 T CY 20171100146T CY 171100146 T CY171100146 T CY 171100146T CY 1118806 T1 CY1118806 T1 CY 1118806T1
- Authority
- CY
- Cyprus
- Prior art keywords
- yloxy
- pharmaceuticals
- formula
- cycloalkane
- calcium
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000026683 transduction Effects 0.000 abstract 2
- 238000010361 transduction Methods 0.000 abstract 2
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 102100035088 Sodium/calcium exchanger 1 Human genes 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 230000004094 calcium homeostasis Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108010067207 sodium-calcium exchanger 1 Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται στα υποκατεστημένα χρωμαν-6-υλοξυ-κυκλοαλκάνια του χημικού τύπου (I), στον οποίο τα Ar, R1 έως R4, p και q υφίστανται, όπως ορίζονται στις αξιώσεις. Οι ενώσεις του χημικού τύπου (I) είναι αναστολείς του συστήματος αντιμεταφοράς νατρίου-ασβεστίου (NCX), ειδικότερα του συστήματος αντιμεταφοράς νατρίου-ασβεστίου του χημικού υποτύπου 1 (NCX1), και είναι κατάλληλοι για την θεραπευτική αντιμετώπιση πολυποίκιλων διαταραχών, στις οποίες διαταράσσεται η ενδοκυτταρική ομοιόσταση ασβεστίου, όπως είναι οι αρρυθμίες, η καρδιακή ανεπάρκεια και το εγκεφαλικό. Η εφεύρεση περαιτέρω αναφέρεται σε διαδικασίες για την παρασκευή των ενώσεων του χημικού τύπου (I), τη χρήση τους ως φαρμακευτικές ουσίες, και φαρμακευτικές συνθέσεις που τις περιέχουν.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305263 | 2013-03-08 | ||
| EP14710222.2A EP2964623B1 (en) | 2013-03-08 | 2014-03-07 | Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals |
| PCT/EP2014/054417 WO2014135674A1 (en) | 2013-03-08 | 2014-03-07 | Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1118806T1 true CY1118806T1 (el) | 2018-01-10 |
Family
ID=47901924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20171100146T CY1118806T1 (el) | 2013-03-08 | 2017-02-01 | Υποκατεστημενα χρωμαν-6-υλοξυ-κυκλοαλκανια και η χρηση τους ως φαρμακευτικες ουσιες |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9440941B2 (el) |
| EP (1) | EP2964623B1 (el) |
| JP (1) | JP6282674B2 (el) |
| KR (1) | KR20150128835A (el) |
| CN (1) | CN105008341B (el) |
| AR (1) | AR095057A1 (el) |
| AU (1) | AU2014224579B2 (el) |
| BR (1) | BR112015020259A2 (el) |
| CA (1) | CA2901220C (el) |
| CY (1) | CY1118806T1 (el) |
| DK (1) | DK2964623T3 (el) |
| ES (1) | ES2614050T3 (el) |
| HR (1) | HRP20170147T1 (el) |
| HU (1) | HUE032932T2 (el) |
| IL (1) | IL240177A (el) |
| LT (1) | LT2964623T (el) |
| MX (1) | MX358669B (el) |
| PL (1) | PL2964623T3 (el) |
| PT (1) | PT2964623T (el) |
| RU (1) | RU2666350C2 (el) |
| SG (1) | SG11201506091QA (el) |
| SI (1) | SI2964623T1 (el) |
| TW (1) | TWI633095B (el) |
| WO (1) | WO2014135674A1 (el) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9701671B2 (en) * | 2015-02-20 | 2017-07-11 | Canon Kabushiki Kaisha | Organic compound, electrochromic element containing the same, optical filter, lens unit, imaging device, and window component |
| CN108939075A (zh) * | 2018-07-26 | 2018-12-07 | 陕西师范大学 | Ncx1基因作为治疗呼吸暂停综合症的药物干预靶点的应用 |
| CN113968883A (zh) * | 2020-07-23 | 2022-01-25 | 南京工业大学 | 光学色酮衍生物及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5952421B2 (ja) * | 1976-07-31 | 1984-12-19 | コニカ株式会社 | 色素画像褪色防止剤を含有するカラ−写真材料 |
| JPH0967336A (ja) | 1995-09-04 | 1997-03-11 | Kanebo Ltd | 新規なイソチオウレア誘導体 |
| EP0978506B1 (en) | 1997-03-27 | 2003-01-08 | Taisho Pharmaceutical Co., Ltd | 2-phenoxyaniline derivatives |
| AU2001295951A1 (en) | 2000-10-18 | 2002-04-29 | Senju Pharmaceutical Co. Ltd. | Novel 4-benzyloxyphenyl derivative and use thereof |
| FI20011507A0 (fi) * | 2001-07-10 | 2001-07-10 | Orion Corp | Uusia yhdisteitä |
| WO2004000813A1 (ja) | 2002-06-25 | 2003-12-31 | Yamanouchi Pharmaceutical Co., Ltd. | フェノキシピリジン誘導体又はその塩 |
| FI20030030A0 (fi) * | 2003-01-09 | 2003-01-09 | Orion Corp | Uusia yhdisteitä |
| TWI346112B (en) * | 2004-02-25 | 2011-08-01 | Nissan Chemical Ind Ltd | Benzopyran compound |
| JP5092111B2 (ja) | 2007-02-05 | 2012-12-05 | トーアエイヨー株式会社 | ブトキシアニリン誘導体 |
| EP2103939A1 (en) | 2008-03-20 | 2009-09-23 | sanofi-aventis | Fluorescence based assay to detect sodium/calcium exchanger (NCX) "reverse mode" modulating compounds |
| EP2348859B1 (en) | 2008-10-01 | 2013-12-04 | Merck Sharp & Dohme Corp. | Prodrugs of oxazolidinone cetp inhibitors |
| EP2567958B1 (en) * | 2011-09-12 | 2014-10-29 | Sanofi | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
| US8912224B2 (en) | 2011-09-12 | 2014-12-16 | Sanofi | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
-
2014
- 2014-03-06 TW TW103107572A patent/TWI633095B/zh not_active IP Right Cessation
- 2014-03-07 EP EP14710222.2A patent/EP2964623B1/en active Active
- 2014-03-07 HU HUE14710222A patent/HUE032932T2/en unknown
- 2014-03-07 ES ES14710222.2T patent/ES2614050T3/es active Active
- 2014-03-07 DK DK14710222.2T patent/DK2964623T3/da active
- 2014-03-07 CA CA2901220A patent/CA2901220C/en not_active Expired - Fee Related
- 2014-03-07 LT LTEP14710222.2T patent/LT2964623T/lt unknown
- 2014-03-07 US US14/772,375 patent/US9440941B2/en active Active
- 2014-03-07 SI SI201430142A patent/SI2964623T1/sl unknown
- 2014-03-07 AR ARP140100756A patent/AR095057A1/es unknown
- 2014-03-07 AU AU2014224579A patent/AU2014224579B2/en not_active Ceased
- 2014-03-07 MX MX2015010961A patent/MX358669B/es active IP Right Grant
- 2014-03-07 KR KR1020157027617A patent/KR20150128835A/ko not_active Application Discontinuation
- 2014-03-07 PL PL14710222T patent/PL2964623T3/pl unknown
- 2014-03-07 JP JP2015560706A patent/JP6282674B2/ja active Active
- 2014-03-07 PT PT147102222T patent/PT2964623T/pt unknown
- 2014-03-07 RU RU2015142274A patent/RU2666350C2/ru not_active IP Right Cessation
- 2014-03-07 SG SG11201506091QA patent/SG11201506091QA/en unknown
- 2014-03-07 BR BR112015020259A patent/BR112015020259A2/pt not_active Application Discontinuation
- 2014-03-07 CN CN201480012406.XA patent/CN105008341B/zh active Active
- 2014-03-07 WO PCT/EP2014/054417 patent/WO2014135674A1/en active Application Filing
-
2015
- 2015-07-27 IL IL240177A patent/IL240177A/en active IP Right Grant
-
2017
- 2017-01-30 HR HRP20170147TT patent/HRP20170147T1/hr unknown
- 2017-02-01 CY CY20171100146T patent/CY1118806T1/el unknown
- 2017-03-08 US US15/225,271 patent/US20170166548A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121395T1 (el) | Τετραϋδροπυριδοπυραζινες-διαμορφωτες toy gpr6 | |
| CY1123417T1 (el) | Παραγωγα τετρα�δροϊσοκινολινης | |
| EA201692280A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| BR112015004111A2 (pt) | novos derivados bicíclicos | |
| MX2021003792A (es) | Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2. | |
| CY1120515T1 (el) | Παραγωγο κυκλοαλκυλικο οξεος, μεθοδος παρασκευης και φαρμακευτικη εφαρμογη αυτου | |
| EA201591805A1 (ru) | Оксабицикло [2.2.2] кислоты - модуляторы gpr120 | |
| MX2017014035A (es) | Formas solidas novedosas. | |
| EA201691982A1 (ru) | 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов | |
| EA201591815A1 (ru) | Бицикло [2.2.2] кислоты - модуляторы gpr120 | |
| EA201691141A1 (ru) | Соединения против ccr6 | |
| EA202090368A1 (ru) | Соединения-ингибиторы рецептора лизофосфатидной кислоты 1 (lpar1) | |
| EA201790496A1 (ru) | Соединения 1-алкил-6-оксо-1,6-дигидропиридин-3-ила и применение в качестве модуляторов sgrm | |
| EA201791058A1 (ru) | Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4) | |
| EA201790570A1 (ru) | Модуляторы р2х7 | |
| EA201891342A1 (ru) | Изоиндольные соединения | |
| EA201890534A1 (ru) | Новые аннелированные феноксиацетамиды | |
| EA201792425A1 (ru) | Трициклические соединения и их применение в качестве ингибиторов фосфодиэстераз | |
| CY1122381T1 (el) | Παραγωγα ιμιδαζοπυριδαζινης ως αναστολεις pi3kbhta | |
| EA201891506A1 (ru) | Индолиноновые соединения и их применение в лечении фиброзных заболеваний | |
| EA201692063A1 (ru) | Спиросоединения мочевины в качестве противовирусных соединений против rsv | |
| PH12019500822A1 (en) | Crystalline forms of eravacycline | |
| CY1123744T1 (el) | Παραγωγα πυριδινυλιου, φαρμακευτικες συνθεσεις και χρησεις αυτων ως αναστολεων aoc3 | |
| CY1118806T1 (el) | Υποκατεστημενα χρωμαν-6-υλοξυ-κυκλοαλκανια και η χρηση τους ως φαρμακευτικες ουσιες | |
| CY1124838T1 (el) | Αλας παραγωγου κεφαλοσπορινης, κρυσταλλικη, στερεη μορφη αυτου και μεθοδος παραγωγης αυτου |